Bedinvetmab - CAS 2171034-69-6

Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) engineered to target nerve growth factor (NGF) . Bedinvetmab prevents NGF from binding its receptors, tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR) . Bedinvetmab is primarily utilized in osteoarthritis research, where it is studied for its ability to manage pain in canine models.

Others, Trk receptor

Tyrosine Kinase/Adaptors, Others

2170959

0.98

-20°C

Ice Packs

Inhibitory Antibodies